HomeMBX • NASDAQ
add
MBX Biosciences Inc
Previous close
$10.65
Day range
$10.39 - $11.17
Year range
$4.81 - $26.19
Market cap
373.02M USD
Avg Volume
333.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 26.53M | 99.26% |
Net income | -23.88M | -93.56% |
Net profit margin | — | — |
Earnings per share | -0.71 | — |
EBITDA | -26.45M | -99.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 240.79M | 242.43% |
Total assets | 245.93M | 226.51% |
Total liabilities | 10.50M | 74.78% |
Total equity | 235.42M | — |
Shares outstanding | 33.42M | — |
Price to book | 1.51 | — |
Return on assets | -25.78% | — |
Return on capital | -26.90% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -23.88M | -93.56% |
Cash from operations | -22.68M | -111.75% |
Cash from investing | 3.23M | -79.09% |
Cash from financing | 4.00K | -97.81% |
Net change in cash | -19.45M | -496.74% |
Free cash flow | -13.58M | -185.87% |
About
Founded
2018
Headquarters
Website
Employees
43
